December 06, 2024

Scientists Receives ERC Consolidator Grant – Funding for the Central Institute of Mental Health

Scientists Receives ERC Consolidator Grant – Funding for the Central Institute of Mental Health

An ERC Consolidator Grant will go to PD Dr Gordon Feld, who does research into sleep and memory at the Central Institute of Mental Health in Mannheim and teaches at Ruperto Carola’s Institute of Psychology.

PD Dr Gordon Feld | © Daniel Lukac/ZI

Dr Feld’s project, entitled “Tracking Memory During Sleep: Understanding How Replay of Complex Information Affects Memory and Mental Health” (MemoryTracker), is about how memories are processed during sleep and their potential capacity for treating mental disorders. His research focuses on discovering how current research findings can be transferred – inter alia with the aid of modern neuroscientific methods – into practical psychotherapeutic options. The European Research Council has allocated approximately two million euros to fund the studies over five years. Since 2019, Gordon Feld has headed the Emmy Noether Group “Psychology and Neurobiology of Sleep and Memory”, which is located in the Department Clinical Psychology at the Central Institute of Mental Health. The researcher also teaches at Heidelberg University’s Institute of Psychology.

The European Research Council awards the ERC Consolidator Grant to outstanding researchers with the aim of consolidating their academic independence. The central criterion for funding is scientific excellence.

Our latest News

discover more
Strategic alliance for rare diseases: RHEACELL and AOP Health enter into strategic partnership to commercialize novel somatic cell therapies in Europe

Strategic alliance for rare diseases: RHEACELL and AOP Health enter into strategic partnership to commercialize novel somatic cell therapies in Europe

Heidelberg/Germany, May 27, 2025. RHEACELL announced today that it has entered into an exclusive partnership agreement with the AOP Health Group, who will commercialize RHEACELL’s two stem cell products, EBESANAR® and AMESANAR®, in Europe, Turkey, Israel and the MENA region (Middle East and Northern Africa). RHEACELL retains full commercialization rights to EBESANAR® and AMESANAR® in […]

Explainable artificial intelligence increases the accuracy and endurance of dermatologists in melanoma diagnosis

Explainable artificial intelligence increases the accuracy and endurance of dermatologists in melanoma diagnosis

Scientists at the German Cancer Research Center (DKFZ) have shown in an international eye-tracking study that dermatologists not only improve their diagnostic accuracy by using explainable artificial intelligence, but also show significantly less fatigue when assessing challenging cases. The researchers were able to demonstrate this by measuring a reduction in cognitive stress indicators. In a […]

Excellence Strategy: HITS researchers successful with two clusters on astrophysics and life sciences

Excellence Strategy: HITS researchers successful with two clusters on astrophysics and life sciences

How do stellar explosions or the evolution of galaxies influence our universe today? How can synthetic biology and specially designed cells aid in the protection of our immune system against infections and cancer? Tackling these research questions from different disciplines is the endeavor of two projects that have been selected as Clusters of Excellence in the […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp